BPH Global (ASX:BP8) has this week signed a significant seaweed offtake agreement with Quanzhou Bailijie Biotechnology, a Chinese carrageenan producer.
Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.
The deal revolves around the monthly sale of BPH’s raw seaweed products, with 100 metric tons of high-quality Eucheuma cottonii seaweed to now be shipped to Quanzhou. That will then expand to as much as 500 tons by 2027.
“We’ve been so impressed with the factories in China,” BP8 CEO Matthew Leonard said, speaking to HotCopper on the major deal heading into Week 16.
“BPH Global is very happy about this two-year agreement – it’s a significant offtake agreement. That potential to scale up to 500 tons a month [is exciting] and we’re really looking forward to working with this great client now.”
Mr Leonard added the plan now is to “grow up” through the two-year deal.
BP8 has been trading relatively flat today and sits at 0.3cps.
Join the discussion. See what HotCopper users are saying about BPH Global and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。